EHCM / Empirical Health Care Management

Empirical analysis of market access of health technologies, the role of innovation and the effects of regulated health care markets on agent behaviour

Utilization and adoption of pharmaceuticals by physicians of ambulatory care

Physicians are typically faced with a multitude of influences when making choices to prescribe pharmaceuticals to patients. In this project, we study the role of information and regulation on utilization and adoption of health technology products. We account for different product types (e.g., new products, biosimilars, generics). We use econometric analyses to study the effects of varying information signals (reimbursement decisions) and the role of regulation (e.g., quotas, budgets) at different levels of the health care system.

Early benefit assessment of innovative pharmaceuticals according to AMNOG in Germany: empirical analysis of the decision-making process

By introducing the Act on the Reform of the Market for Medicinal Products (Arzneimittelmarktneuordnungsgesetz) in 2010, the regulatory framework for pharmaceuticals has changed for Germany. Manufacturers need to demonstrate a product’s health benefit and must negotiate prices accordingly. We aim to identify factors that determine the decision on added health benefit and prices. We differentiate between the quality of evidence, its presentation, technological characteristics, and process related aspects. We use a database of decisions and perform econometric analyses.

Collaborating institution: Hamburg Center for Health Economics, University of Hamburg

The impact of biomedical innovation on medication non-adherence

Medication non-adherence has been identified as substantial source of waste across health care systems. In this project, we study the influence of pharmaceutical innovation on adherence behavior in the working population in Germany and the United States. We focus on analyses of chronic conditions using real world data on drug utilization.

Collaborating institution: Columbia Business School, Columbia University, DocMorris